Accessibility Menu
 
Opthea logo

Opthea

(NASDAQ) OPT

Current PriceN/A
Market CapN/A
Since IPO (2012)-100%
5 Year-100%
1 Year-99%
1 Month-61%

Opthea Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$207.57K

Net Income (TTM)

$496.19M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

OPT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Opthea

Industry

Biotechnology

CEO

Frédéric Guerard, PharmD

Headquarters

South Yarra, VIC 3141, AU

OPT Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-610%

Net Income Margin

-1014%

Return on Equity

1%

Return on Capital

73%

Return on Assets

-4%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$38.36K

Operating Income

$239.00M

EBITDA

$189.00M

Operating Cash Flow

$243.00M

Capital Expenditure

$0.00

Free Cash Flow

$243.00M

Cash & ST Invst.

$74.33M

Total Debt

$378.96M

Opthea Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.09K

-98.7%

Gross Profit

$4.56K

+89.8%

Gross Margin

-4.17%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

33

N/A

Net Income

$31.38M

+67.6%

EBITDA

$107.35M

-0.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$198.55M

-248.5%

Accounts Receivable

$7.61M

-22.9%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$246.99M

+101153.6%

Return on Assets

-4.32%

N/A

Return on Invested Capital

73.42%

N/A

Free Cash Flow

$135.67M

-80.6%

Operating Cash Flow

$86.41M

-15.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MRTXMirati Therapeutics, Inc.
$58.70-0.17%
ALPNAlpine Immune Sciences, Inc.
$64.97+0.02%
RYZBRayzeBio, Inc. Common Stock
$62.49+0.02%
CBAYCymaBay Therapeutics, Inc.
$32.48+0.03%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About OPT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.